Cynosure Inc. achieves revenue record in the fourth quarter and in the year 2012.

-the subsidiary of Cynosure in Spain, grew up in 2012 21% more than in the period of the previous year and Q4, 14% more than in the same period from 2012

-earnings per share amounted to 0.27 dollar in the last quarter and 0.79 dollars full-year

-the company has with liquid 146.7 million resources

Madrid, February 2013- Cynosure, Inc. (Nasdaq: CYNO) has closed the best quarter in its history with revenue of $ 42.7 million, which is 25% more than the 34.1 million reported in the same period of the previous year. At the same time, the year 2012 has also been the best of its history, thanks to revenues of $ 153.5 million, 39% more than the 110,6 million in 2011.

Our commitment by having workstations aesthetic industry leaders and be technologically very innovative has allowed us to generate solid results in 2012, ” assures Michael Davin, President and CEO of Cynosure. “We believe we are well positioned to maintain this momentum over the next year. The demand in North America and the international market has helped to produce a historical performance for the company in the fourth quarter and full year. At the same time, continue to enhance the efficiency of our operations allowing us to raise our margins and significantly strengthen the final outcome. ”

net income soars in the quarter and in the year

net profit for the fourth quarter amounted to $ 4 million, which means multiplying by 3.6 times (equivalent to a growth of 260%) achieved in the same quarter of 2011. Earnings per share stood at 0.27 dollars to 0.08 dollars from twelve months earlier. The improvement was mainly due to the increase of income and the improvement of operational efficiency. Furthermore, the net benefit of 2012 reached 11 million dollars (0.79 dollars per share), compared to the loss of 2.9 million dollars in the previous year.

By business areas, generated by laser products revenues increased 28% in the fourth quarter to 36.5 million dollars, while that in annual terms the rise was 45% to 128.5 million. This significant increase reflects the launch in United States Cellulaze minimally-intrusive technology platform ™ in 2012 and the strong demand for other devices like the Elite product family ™, MedLite ® C6 and RevLite ® platforms and Smartlipo ® laser lipolysis system.

Star Cellulaze, our new product, not only still an excellent acceptance among plastic surgeons who are customers for the first time of Cynosure, but also among those who have decided to upgrade their platforms Smartlipo MPX ™ and Smartlipo Triplex ™, ” said Darvin. Which adds to compared with the fourth quarter of 2011, area laser North American revenues grew 44% quarterly, while the international segment international. increased 14% in our European subsidiaries and Asian and distribution channels ”

in Spain also Cellulaze is the top product and has led to an increase in sales in 2012 of the 28% and have an expectation of 10% more this year ”, according to the Director General of the subsidiary Ibérica, Juan Antonio López Moreno.

The gross margin of the last three months of 2012 rose to 58.1%, compared to 56.3% for the same period in 2011. This year over year improvement is mainly due to the increase in sales of products with higher margins and increased revenues from North America, where average sales prices tend to be higher. If we take into account the full financial year 2012, gross margin was 57.9% compared to 56.3% in 2011.

Meanwhile, operating expenses in the fourth quarter reached the 20.6 million dollars, equivalent to 48% of revenues, four percentage points below the level of the previous year. For the whole year, total operating costs accounted for 50% of revenue, with an improvement of 8.2 percentage points from the year 2011.

Continue to enhance our operational efficiency thanks to a good portfolio of products and the control of costs, which translates into improved efficiency ratios, ” is the President and CEO of Cynosure. after the public offering led out in November last year, we have a $ 147 billion liquidity position and have no long-term debt. We are convinced that our financial resources place us in a special position to face the future and it provides us more capacity to consider the opportunities that meet the criteria of our growth strategy.”

Innovation is the key to Cynosure note this quantitative and qualitative growth of exponential form, therefore, is important to highlight the introduction on the Portuguese market of the Pinpointe and demand in the neighboring country of technology quality laser. According to López, Portugal will in 2013 fruit of many satisfactions since, currently, it means 10% of the installed base of the total in the peninsula, and I am sure that this figure will increase considerably ”.

About Cynosure

Cynosure, Inc. (Nasdaq: CYNO), is a pioneer, manufacturer and a leader in lasers for medical and aesthetic applications. Born in 1991 in the United States, is present in more than 60 countries and has installed more than 5,000 lasers worldwide. Cynosure comes to Spain in 2004, www.cynosurespain.com where it has delegations and specialists throughout the country and in 2013 it extends to Portugal.
Cynosure lasers allow procedures non-invasive and minimally invasive: on the one hand, the removal of hair, treatment of vascular lesions, all types of treatments for rejuvenation of the skin, treatment of vascular and pigmented, treatments of acne lesions, scars, psoriasis and Onychomycosis: Elimination of the fungus by laser; and on the other hand, the body contouring: laser lipolysis improved by stretching of the skin, body contouring treatment and the Elimination of the cellulitis with Cellulaze.

Cellulaze has been one of the latest innovations, the first and only device laser minimally invasive, designed to permanently eliminate cellulite from within and in the long term, restoring the normal structure of the skin and the underlying tissue.

The future of Cynosure is extraordinarily bright as his innovations approach them at the highest levels of technological superiority. On its website www.cynosurespain.com you can locate the nearest doctor technology Cynosure.